447 results on '"A. Boletta"'
Search Results
2. Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression
3. Il Registro Italiano del Rene Policistico Autosomico Dominante
4. Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression
5. Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis
6. Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis
7. Primary cilia sense glutamine availability and respond via asparagine synthetase
8. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
9. #2048 Exploring somatic mutation mechanisms in pre-cystic renal cells of autosomal dominant polycystic kidney disease patients
10. #1193 Tracking kidney cancer initiation via somatic mutation analysis of pre-cancer cells from Von Hippel Lindau cancer predisposition syndrome
11. Disruption of polycystin-1 cleavage leads to cardiac metabolic rewiring in mice
12. Spatial metabolic tracing in the kidney — the future is now
13. In SILICO Simulations Predict a Causative Link Between Increased Glycolysis and Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease.
14. The Biogenesis of Polycystin 1 Requires Active AQP11 at the ER Membrane
15. Primary cilia sense glutamine availability and respond via asparagine synthetase
16. Mechanosensory Genes Pkd1 and Pkd2 Contribute to the Planar Polarization of Brain Ventricular Epithelium.
17. Reversing polycystic kidney disease
18. Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression
19. Metabolism and mitochondria in polycystic kidney disease research and therapy
20. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC ‐driven lymphoma
21. Cleavage of Polycystin-1 Requires the Receptor for Egg Jelly Domain and Is Disrupted by Human Autosomal-Dominant Polycystic Kidney Disease 1-Associated Mutations
22. Polycystin-1 Regulates Actomyosin Contraction and the Cellular Response to Extracellular Stiffness
23. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in <scp>MYC</scp> ‐driven lymphoma
24. Primary cilia sense glutamine availability and respond via asparagine synthetase.
25. mTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression
26. Metabolic reprogramming in polycystic kidney disease explained by super-enhancers and CDK7: new therapeutic targets?
27. Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
28. Targeting the Mitochondrial Protease Clpp Unveils Mitochondrial Vulnerabilities in Multiple Myeloma
29. Intracellular Iron Overload Induces Metabolic Switching in Active Hematopoietic Stem Cells in Beta-Thalassemia
30. Defective glycolysis and the use of 2-deoxy-d-glucose in polycystic kidney disease: from animal models to humans
31. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells
32. Políticas públicas dos EUA e da China para a pandemia: tensões geopolíticas, competição tecnológica e modelos de desenvolvimento
33. Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
34. Spatial metabolic tracing in the kidney — the future is now
35. P-109: ER-phagic control of lipid metabolism supports multiple myeloma cell survival
36. P-111: Targeting the mitochondrial protease ClpP unveils novel vulnerabilities in multiple myeloma
37. Role of the polycystins as mechanosensors of extracellular stiffness
38. Targeting the Mitochondrial Protease Clpp Unveils Mitochondrial Vulnerabilities in Multiple Myeloma
39. Intracellular Iron Overload Induces Metabolic Switching in Active Hematopoietic Stem Cells in Beta-Thalassemia
40. Oxidative stress potentiates the therapeutic action of a mitochondrial complex I inhibitor in MYC-driven B-cell lymphoma
41. Oxidative stress potentiates the therapeutic action of a mitochondrial complex I inhibitor in MYC-driven B-cell lymphoma
42. P1563: INTRACELLULAR IRON OVERLOAD IMPAIRS HSC FUNCTION BY AFFECTING MITOCHONDRIAL FITNESS IN ΒETA-THALASSEMIA
43. Characterization of the PKD 1 Gene Product, Polycystin-1
44. https://www.puntoorginternationaljournal.org/index.php/PIJ/article/view/90
45. Research Data in Journals and Repositories in the Web of Science: Developments and Recommendations.
46. Spatial metabolic tracing in the kidney — the future is now
47. Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression
48. The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity
49. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease
50. Políticas públicas dos EUA e da China para a pandemia: tensões geopolíticas, competição tecnológica e modelos de desenvolvimento
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.